Josephine Taverna, MD
NOTE : If you're an existing patient, please connect via MyChart
-
About Me
About Josephine Taverna, MD
Josephine Taverna, MD, was born in Guadalajara, Mexico, and raised in New York City. She is an associate professor in the Division of Hematology Oncology and the Department of Molecular Medicine at The University of Texas Health Science Center San Antonio. She specializes in treating patients with thoracic cancers at Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center.
She graduated with her undergraduate degree in molecular biophysics and biochemistry from Yale University and received her medical degree from Mount Sinai School of Medicine. She completed her residency in internal medicine at the Cleveland Clinic Akron General in Akron, Ohio, and her fellowship training in hematology-oncology at the University of Arizona in Tucson, Arizona. She completed research fellowships in skin oncology at Boston Medical Center in Boston, Massachusetts, drug development at the Institute for Drug Development at UT Health San Antonio and cancer prevention and control at the University of Arizona.
She’s a physician-scientist whose research is focused on harnessing single-cell omics from the bench to select targeted therapies for lung cancer patients. Recently, she has been developing an independent research program in lung cancer therapeutics at Mays Cancer Center.
Gender
- Female
Languages Spoken
- English
- Spanish
- Italian
- French
-
Credentials
Credentials
Positions
- Associate Professor, Division of Hematology Oncology, University of Texas Health Science Center San Antonio
- Associate Professor, Department of Molecular Medicine, University of Texas Health Science Center San Antonio
Education
Medical School: Mount Sinai School of Medicine, New York, NY
Fellowship: Hematology-Oncology, University of Arizona, Tucson, AZ
Residency: Internal Medicine, University of Vermont College of Medicine, Akron, OH
Fellowship: Research, Skin Oncology, Boston Medical Center, Boston, MA
Internship: Internal Medicine, Boston Medical Center, Boston, MA
Undergraduate: BS, Molecular Biophysics & Biochemistry, Yale University, New Haven, CT -
Locations & Contact
Locations & Contact
Dr. Taverna is absolutely outstanding in every way. I would highly recommend.
Patient
-
Research & Publications
Research & Publications
Single-Cell Proteomic Profiling Identifies Combined AXL and JAK1 Inhibition as a Novel Therapeutic Strategy for Lung Cancer
Taverna JA, Hung CN, DeArmond DT, Chen M, Lin CL, Osmulski PA, Gaczynska ME, Wang CM, Lucio ND, Chou CW, Chen CL, Nazarullah A, Lampkin SR, Qiu L, Bearss DJ, Warner S, Whatcott CJ, Mouritsen L, Wade M, Weitman S, Mesa RA, Kirma NB, Chao WT, Huang TH.
Role of Maintenance Therapy after High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation in Aggressive Lymphomas: A Systematic Review.
Taverna JA, Yun S, Jonnadula J, Saleh A, Riaz IB, Abraham I, Yeager AM, Persky DO, McBride A, Haldar S, Anwer F.
Blood and Marrow Transplantation. 2016; 22(7):1182-96.
Phosphodiestease 4 Inhibitors Augment Levels of Glucocorticoid Receptor in B Cell Chronic Lymphocytic Leukemia but Not in Normal Circulating Hematopoietic Cells.
Meyers JA, Taverna JA, Chaves J, Makkinje A, Lerner A.
Clin Cancer Res. 2007;13:4920-4927.
View All Publications - Josephine Taverna, MD
- Clinical Trials